Faculty Opinions recommendation of Short-Term Teriparatide and Recombinant Human Bone Morphogenetic Protein-2 for Regenerative Approach to Medication-Related Osteonecrosis of the Jaw: A Preliminary Study.

Author(s):  
Mark Johnson
Sign in / Sign up

Export Citation Format

Share Document